@FierceBiotech: Third Rock's Levin calls for teamwork in personalized medicine by @DamianFierce. Report | Follow @FierceBiotech
@RyanMFierce: GSK's pursuit of HGSI has gone hostile as Glaxo goes directly to HGS investors with $2.6B tender offer. News | Follow @RyanMFierce
> FDA staff reviewed Gilead's ($GILD) Truvada, supporting the safety and efficacy of the HIV med as a preventive treatment for people at risk of contracting the virus. Item
> Johnson & Johnson ($JNJ) wants to get approval for its blockbuster contender Xarelto to prevent blood clots from forming in patients with heart stents. Article
> India's drug regulator and pharma outfits have been in cahoots, a study finds, highlighting concerns about lenient oversight of meds in India. Report
Pharma News
@FiercePharma: New DSM won't make grief an illness. Panel also cuts two proposed diagnoses of psychosis and anxiety/depression--NYT. Article | Follow @FiercePharma
> Lipitor copy powers a surge in Ranbaxy sales, profits. Report
> Advisory panels take up Gilead's Truvada, then Quad. More
> Senate probes ties among narcoticsmakers, pain organizations. Story
@FierceMedDev: Covidien bought Maya Medical, the maker of a renal denervation treatment, and barely acknowledged it. Item | Follow @FierceMedDev
> Hygieia releases study results for its new hand-held insulin device. Article
> St. Jude armed with FDA approval for Ellipse ICD. Report
> Given Imaging revenue jumps overall, due to Americas PillCam sales. More
> Covidien grabs Maya Medical for $60M-plus. Item
Drug Delivery News
@DamianFierce: The coming onslaught of blockbuster knockoffs could be a huge opportunity for drug delivery firms. News | Follow @DamianFierce
> Charge-changing nanoparticles can help kill resistant bacteria. More
> pSivida gets U.K. nod for behind-the-eye treatment. Article
> Echo's trandsdermal tech gets positive results, TV time. News
> Patent cliff could create need for novel delivery tech. Item
> MonoSol, Midatech tout positive Phase I for insulin film. Story
Biomarkers News
> Targeted therapies need cost-effective biomarkers. More
> DNA changes could predict prostate cancer relapse. Article
> 15-minute test could tag Alzheimer's. Story
> Biosignatures fingerprint tuberculosis and sarcoidosis. Story
And Finally… Details are revealed about the science involved in the diet that keeps pop idol Madonna looking young at 53. Report